Metformin offers a logical alternative to insulin in gestational diabetes and type 2 diabetes in pregnancy as it produces euglycemia by reducing insulin resistance, improving insulin sensitivity, reducing hepatic gluconeogenesis, and increasing peripheral glucose uptake and utilization. The gene discussed is INS; the disease is gestational diabetes.